A study based on 458 Chinese patients with thyroid cancer reported that the prevalence of BRAF driver mutations is 76.0%, followed by RET rearrangements (7.6%), while the prevalence of RAS mutations is only 4.1% (9). The gene discussed is BRAF; the disease is thyroid gland carcinoma.